(Q37792614)

English

Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis

scientific article published on September 25, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

Sub-Saharan Africa

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

author name string

Quirine Huijgen

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Jantjie Taljaard

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Roos E. Barth

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20870439

20 July 2024

Andy I. M. Hoepelman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20870439

20 July 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

full work available at URL

http://www.ijidonline.com/article/S1201971210024562/pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20870439

20 July 2024

https://api.elsevier.com/content/article/PII:S1201971210024562?httpAccept=text/xml

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

https://api.elsevier.com/content/article/PII:S1201971210024562?httpAccept=text/plain

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

International Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

e1024-31

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Hepatitis B and human immunodeficiency virus coinfection

3

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.

4

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression

5

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

6

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Meta-analysis in clinical trials

7

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified

8

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Development and validation of MIX: comprehensive free software for meta-analysis of causal research data

9

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana

10

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Prevalence of Human Herpes Virus-8 and Hepatitis B Virus among HIV Seropositive Pregnant Women Enrolled in the Mother-to-child HIV Transmission Prevention Program at Saint Camille Medical Centre in Burkina Faso

11

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso

12

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis

13

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina Faso).

14

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso

15

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

HIV and Hepatitis C Virus Coinfection, Cameroon

16

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Serological findings amongst first‐time blood donors in Yaoundé, Cameroon: is safe donation a reality or a myth?

17

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic.

18

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo

19

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study

20

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Côte d'Ivoire, West Africa

21

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia

23

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia

24

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia

26

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Infection with HIV, syphilis and hepatitis B in Ethiopia: a survey in blood donors

27

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Relationship between immunoclinical status and prevalence of viral sexually transmitted diseases among human immunodeficiency virus-1 seropositive patients in Ghana

28

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

HIV, hepatitis B and hepatitis C coinfection in Kenya

29

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.

32

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi

33

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women

34

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Seroprevalence of HIV/HBV coinfection in Malian blood donors

35

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

HIV/HCV coinfection in Infectious Disease Units in Mozambique and Brazil: a comparative study

36

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique

37

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B and C virus co-infection in Nigerian patients with HIV infection.

38

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Does immunological status affect the prevalence of Hepatitis C virus infection among HIV/AIDS patients?

40

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria

41

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria

44

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes

45

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Prevalence of HIV-positives and hepatitis B surface antigen-positives among donors in the University of Benin Teaching Hospital, Nigeria.

46

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

HIV association with conventional STDS (sexual transmitted diseases) in Lagos State, Nigeria

48

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).

49

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.

50

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa

51

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program

52

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naïve patients is associated with renal insufficiency and increased mortality

53

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women

54

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa

55

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg

56

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Serological markers of sexually transmitted diseases associated with HIV-1 infection in pregnant black women

57

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania

58

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Seroprevalence of hepatitis B and C viruses among women of childbearing age in Moshi Urban, Tanzania.

59

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania

60

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Seroprevalence of hepatitis C virus in the general population of northwest Tanzania

61

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania

62

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda

64

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B virus and hiv infections among patients in Mulago hospital.

65

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areas

66

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B virus activation among central Africans infected with human immunodeficiency virus (HIV) type 1: pre-s2 antigen is predominantly expressed in HIV infection

67

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia

68

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Low prevalence of hepatitis C virus antibodies in HIV-endemic area of Zimbabwe support sexual transmission as the major route of HIV transmission in Africa

69

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa

70

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

71

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: a 3-yr prospective study

74

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals

75

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis

76

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group

77

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.

78

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

79

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.

80

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.

81

1 reference

10.1016/J.IJID.2010.06.013

https://api.crossref.org/works/10.1016/J.IJID.2010.06.013

20 July 2024

Identifiers

10.1016/J.IJID.2010.06.013

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37792614&oldid=2208758218"